EVENT PREVIEW
Clinical Trial Supply New England 2022
8-9 March 2022
Waltham, MA, US
arena-international.com
Clinical Trial Supply event will gather the key stakeholders in the clinical trials community, including the FDA, US Customs and Border Protection, Biogen, Sanofi, Blueprint Medicines Corporation and many more. With interactive session formats, fresh content and networking, the event will provide attendees with an unparalleled opportunity for collaboration between players across the whole industry.
Clinical trials are becoming increasingly complex, often involving thousands of patients at hundreds of sites around the world. Running these trials smoothly, ensuring they start and finish on time, and within budget, is a significant challenge, not least from a logistics perspective.
Clinical Trial Supply event will gather the key stakeholders in the clinical trials community, including the FDA, US Customs and Border Protection, Biogen, Sanofi, Blueprint Medicines Corporation and many more. With interactive session formats, fresh content and networking, the event will provide attendees with an unparalleled opportunity for collaboration between players across the whole industry.
Clinical trials are becoming increasingly complex, often involving thousands of patients at hundreds of sites around the world. Running these trials smoothly, ensuring they start and finish on time, and within budget, is a significant challenge, not least from a logistics perspective.
Each trial needs to have significant quantities of the trial drug manufactured, packaged, and labelled correctly, stored, and then shipped securely and on time to multiple global locations. Clinical Trials Supply offers practical insights on overcoming the challenges at each of these stages of the clinical trials supply chain.
Don’t miss: Sean Smith, Biological Threat Exclusion Coordinator, US Customs and Border Protection and Adam Pitt, Biological Threat Exclusion Coordinator, US Customs and Border Protection on How to ensure your clinical supplies pass US border control from the CBP perspective
The entire process of a clinical trial is significantly expensive, and trials account for by far the largest portion of the 8 – 10 years and $800mil - $1bil dollars it takes to get a drug to market. Errors in the trials process can be extremely costly – damaging the quality of the outcome results, lengthening the trial, and adding significant cost. Ensuring that the trials run smoothly, without supply problems, is an extremely important task that has huge potential financial ramifications for the trial sponsors (pharma and biotechs).
Pharmaceutical companies are therefore realising the potential of the supply chain as a mean to cutting costs. In doing so, they must therefore view their supply chain in a new, strategic light, as a potential competitive advantage rather than an unavoidable cost centre embedded in day-to-day operations. In the process, they must discard age-old attitudes that once drove nearly uninterrupted success. We’ve been running this event in Boston for 9 years, but the challenges facing the industry are as pertinent as ever. In the past couple of years, the industry has begun to fully digitize trial supply chains, and this offers us opportunity to explore these new solutions which benefit trial sponsors but also opens the event up to new vendors and the producer should explore new technology such as blockchain.
